Lipocalin-type prostaglandin D synthase/β-trace is a major amyloid β-chaperone in human cerebrospinal fluid
暂无分享,去创建一个
Y. Urade | Zhi-Li Huang | I. Mohri | M. Taniike | K. Ozono | S. Murayama | T. Ban | Y. Goto | W. Qu | K. Aritake | T. Kanekiyo | I. Okazaki
[1] S. Narumiya,et al. Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep , 2006, Proceedings of the National Academy of Sciences.
[2] T. Ban,et al. Direct observation of amyloid growth monitored by total internal reflection fluorescence microscopy. , 2006, Methods in enzymology.
[3] T. Ban,et al. αB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid β-peptide and β2-microglobulin , 2005 .
[4] Ilana S. Hairston,et al. Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice , 2005, Cell.
[5] Kaj Blennow,et al. Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. , 2003, Brain research. Molecular brain research.
[6] Robert B Wallace,et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.
[7] Y. Urade,et al. Characterization of the Unfolding Process of Lipocalin-type Prostaglandin D Synthase* , 2003, The Journal of Biological Chemistry.
[8] D. Pfaff,et al. Estradiol differentially regulates lipocalin-type prostaglandin D synthase transcript levels in the rodent brain: Evidence from high-density oligonucleotide arrays and in situ hybridization , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] R. Leapman,et al. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[10] Y. Urade,et al. Development and evaluation of a practical ELISA for human urinary lipocalin-type prostaglandin D synthase. , 2002, Clinical chemistry.
[11] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[12] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[13] T. Kaneko,et al. Cellular localization of lipocalin‐type prostaglandin D synthase (β‐trace) in the central nervous system of the adult rat , 2000, The Journal of comparative neurology.
[14] Y. Urade,et al. Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. , 2000, Biochimica et biophysica acta.
[15] Y. Itoyama,et al. Increased bilirubins and their derivatives in cerebrospinal fluid in Alzheimer’s disease , 2000, Neurobiology of Aging.
[16] Y. Urade,et al. Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Tanzi,et al. A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders. , 1999, The Journal of clinical investigation.
[18] S. Sisodia. Alzheimer's disease: perspectives for the new millennium. , 1999, The Journal of clinical investigation.
[19] H. Toh,et al. Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase. , 1999, Biochemistry.
[20] Y. Urade,et al. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[21] I. Tominaga,et al. Capillary electrophoretic analyses of beta-trace protein and other low molecular weight proteins in cerebrospinal fluid from patients with central nervous system diseases. , 1997, Journal of pharmaceutical and biomedical analysis.
[22] P. Lansbury,et al. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.
[23] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[24] R. Tanzi,et al. REVIEWThe Gene Defects Responsible for Familial Alzheimer's Disease , 1996, Neurobiology of Disease.
[25] Thomas Wisniewski,et al. The Interaction between Apolipoprotein E and Alzheimers Amyloid -Peptide Is Dependent on -Peptide Conformation (*) , 1996, The Journal of Biological Chemistry.
[26] T. Wisniewski,et al. THE INTERACTION BETWEEN APOLIPOPROTEIN E AND ALZHEIMERʼS AMYLOID β-PEPTIDE IS DEPENDENT ON β-PEPTIDE CONFORMATION , 1996 .
[27] Y. Urade,et al. Quantitative Sandwich Enzyme-linked Immunosorbent Assay for Human Secretory Prostaglandin D Synthase (.BETA.-Trace). , 1996 .
[28] C. Wernstedt,et al. Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain , 1995, Neuron.
[29] H. Toh,et al. Structural and Functional Significance of Cysteine Residues of Glutathione-independent Prostaglandin D Synthase , 1995, The Journal of Biological Chemistry.
[30] W. Strittmatter,et al. Transthyretin sequesters amyloid beta protein and prevents amyloid formation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[31] T. Kaneko,et al. Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[32] D. Selkoe,et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.
[33] Thomas Wisniewski,et al. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.
[34] M. Hosokawa,et al. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. , 1989, Analytical biochemistry.
[35] R. E. Pitas,et al. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. , 1987, The Journal of biological chemistry.
[36] E. Thompson. Proteins of the Brain and CSF in Health and Disease , 1983 .
[37] J. Clausen. Proteins in Normal Cerebrospinal Fluid Not Found in Serum.∗ , 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.